Telomere length predicts for outcome to FCR chemotherapy in CLL

por Norris, Kevin, Hillmen, Peter, Rawstron, Andrew, Hills, Robert, Baird, Duncan M., Fegan, Christopher D., Pepper, Chris
Publicado 2019

Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit nuclear factor-κB activity and synergize with bortezomib and ibrutinib in hematologic cancers

por Lewis, Thomas, Corcoran, David B., Thurston, David E., Giles, Peter J., Ashelford, Kevin, Walsby, Elisabeth J., Fegan, Christopher D., Pepper, Andrea G. S., Rahman, Khondaker Miraz, Pepper, Chris
Publicado 2020

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

por Pepper, Andrea G. S., Zucchetto, Antonella, Norris, Kevin, Tissino, Erika, Polesel, Jerry, Soe, Zarni, Allsup, David, Hockaday, Anna, Ow, Pei Loo, Hillmen, Peter, Rawstron, Andrew, Catovsky, Daniel, Bulian, Pietro, Bomben, Riccardo, Baird, Duncan M., Fegan, Christopher D., Gattei, Valter, Pepper, Chris
Publicado 2021

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia

por Cohen, Jared A., Rossi, Francesca Maria, Zucchetto, Antonella, Bomben, Riccardo, Terzi-di-Bergamo, Lodovico, Rabe, Kari G., Degan, Massimo, Steffan, Agostino, Polesel, Jerry, Santinelli, Enrico, Innocenti, Idanna, Cutrona, Giovanna, D’Arena, Giovanni, Pozzato, Gabriele, Zaja, Francesco, Chiarenza, Annalisa, Rossi, Davide, Di Raimondo, Francesco, Laurenti, Luca, Gentile, Massimo, Morabito, Fortunato, Neri, Antonino, Ferrarini, Manlio, Fegan, Christopher D., Pepper, Christopher J., Del Poeta, Giovanni, Parikh, Sameer A., Kay, Neil E., Gattei, Valter
Publicado 2020